SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001262463-12-000205
Filing Date
2012-05-21
Accepted
2012-05-21 16:48:35
Documents
9
Period of Report
2012-03-31
Filing Date Changed
2012-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plpl_form10q3312012.htm 10-Q 220252
2 EXHIBIT 31 exhibit31.htm EX-31 6096
3 EXHIBIT 32 exhibit32.htm EX-32 2696
  Complete submission text file 0001262463-12-000205.txt   1000452

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT plpl-20120331.xml EX-101.INS 57479
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plpl-20120331.xsd EX-101.SCH 11666
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plpl-20120331_cal.xml EX-101.CAL 5839
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plpl-20120331_def.xml EX-101.DEF 46133
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plpl-20120331_lab.xml EX-101.LAB 70925
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plpl-20120331_pre.xml EX-101.PRE 56186
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 206-380-7145
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 201389815 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-51206 | Film No.: 12859379
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1